Correlation Between Quoin Pharmaceuticals and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Foghorn Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Foghorn Therapeutics.
Diversification Opportunities for Quoin Pharmaceuticals and Foghorn Therapeutics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Quoin and Foghorn is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Foghorn Therapeutics
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Foghorn Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Quoin Pharmaceuticals Ltd is 1.18 times less risky than Foghorn Therapeutics. The stock trades about -0.48 of its potential returns per unit of risk. The Foghorn Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 817.00 in Foghorn Therapeutics on August 30, 2024 and sell it today you would lose (38.00) from holding Foghorn Therapeutics or give up 4.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Foghorn Therapeutics
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| Foghorn Therapeutics |
Quoin Pharmaceuticals and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and Foghorn Therapeutics
The main advantage of trading using opposite Quoin Pharmaceuticals and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Quoin Pharmaceuticals vs. Ikena Oncology | Quoin Pharmaceuticals vs. Eliem Therapeutics | Quoin Pharmaceuticals vs. HCW Biologics | Quoin Pharmaceuticals vs. RenovoRx |
| Foghorn Therapeutics vs. Ikena Oncology | Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |